Target intelligence / Profile preview

DNA/RNA synthesis and DNA methylation machinery

Molecular classification
Enzyme, DNA-binding protein, RNA-binding protein, Transcription factor, Epigenetic regulator
01

Overview

The DNA/RNA synthesis and DNA methylation machinery refers to the collective group of enzymes and regulatory proteins responsible for the replication, transcription, and epigenetic modification of nucleic acids. This complex system includes DNA polymerases for replication, RNA polymerases for transcription, and DNA methyltransferases (DNMTs) for the addition of methyl groups to cytosine residues, which regulates gene expression [1][2]. Dysregulation of these processes is a hallmark of various pathologies, most notably cancer, where accelerated synthesis supports rapid proliferation and aberrant methylation leads to the silencing of tumor suppressor genes [3]. Therapeutic strategies targeting this machinery include antimetabolites that deplete nucleotide precursors, nucleoside analogs that incorporate into nascent strands to cause chain termination, and hypomethylating agents that restore normal gene expression patterns [4][5]. While these therapies are foundational in oncology and virology, their lack of absolute specificity for diseased cells often results in significant side effects, such as bone marrow suppression and mucosal damage [6].

Other names
Nucleic acid synthesis machineryDNA replication and transcription machineryEpigenetic modification machineryDNA/RNA metabolic processes
02

Mechanism of action

Inhibition of nucleotide biosynthesis, competitive inhibition of DNA/RNA polymerases, induction of DNA chain termination, and covalent inhibition of DNA methyltransferases to induce hypomethylation [4][5][6].

03

Biological functions

DNA replicationTranscriptionDNA methylationDNA repairEpigenetic regulationCell cycle control
04

Disease associations

CancerViral infectionMyelodysplastic syndromeAutoimmune diseaseHematologic malignancy
05

Safety considerations

MyelosuppressionGastrointestinal toxicityTeratogenicityNephrotoxicityHepatotoxicitySecondary malignancies
06

Interacting drugs

5-Fluorouracil

9 more in the full profile.

07

Biomarkers

MGMT promoter methylation statusMicrosatellite instability (MSI)Ki-67 proliferation indexDNMT1 expression levelsTP53 mutation status

Beyond the preview

Go deeper on DNA/RNA synthesis and DNA methylation machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA/RNA synthesis and DNA methylation machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call